Arthritis of the glenohumeral joint accompanied by an irreparable tear of the rotator cuff can cause severe pain, disability and loss of function, particularly in the elderly population. Anatomical shoulder arthroplasty requires a functioning rotator cuff, however, reverse shoulder arthroplasty is capable of addressing both rotator cuff disorders and glenohumeral deficiencies. The Aequalis Reversed Shoulder Prosthesis design is based on two bio-mechanical principles by Grammont; a medialized center of rotation located inside the glenoid bone surface and second, a 155 degree angle of inclination. Combined, they increase the deltoid lever arm by distalizing the humerus and make the prosthesis inherently stable. 24 consecutive primary reverse total shoulder arthroplasties were performed by a single surgeon for arthritis with rotator cuff compromise and 1 as a revision for a failed primary total shoulder replacement between December 2009 and October 2012. Patients were assessed postoperatively with the use of the DASH score, Oxford shoulder score, range of shoulder motion and plain radiography with Sirveaux score for scapular notching. Mean age at the time of surgery was 72.5 years (range 59 to 86). Average follow up time was 19.4 months (range 4 to 38). Functional outcome scores from our series were comparable with patients from other follow up studies of similar prosthesis design. All patients showed improvement in range of shoulder movement postoperatively. Complications included one dislocation, one acromion fracture and one humeral shaft fracture. No cases of deep infection were recorded. Overall, the short-term clinical results were promising for this series of patients and indicate reverse shoulder arthroplasty as an appropriate treatment for this group of patients.
Magnetic resonance imaging (MRI) continues to become more widely accessible as an investigation, with an increasing number of scans being performed in the outpatient setting for suspected shoulder pathology. We performed a retrospective review of all shoulder MRI scans performed in an orthopaedic outpatient setting in a district general hospital between October 2010 and October 2011. We also reviewed the medical notes for these patients. 75 MRI Shoulder scans were performed on 74 patients. In 5 cases (7%), no other form of imaging was performed prior to MRI scan. 11 patients (15%) had no provisional diagnosis included in the referral. The nature of referral, indication for MRI and subsequent management of these patients was also examined. Our findings may support the use of guidelines for requesting MRI scans of the shoulder in outpatients.
DASH score results were excellent in all bar one of those returned.
These results are comparable to the best results of arthroscopic ACJ Excision.
In this study we intend to evaluate the outcomes for patients with the Rotaglide mobile meniscal knee prosthesis implanted for osteoarthritis. All patients reviewed had this prosthesis implanted as a primary total knee arthroplasty in Crosshouse hospital. The minimum follow up period was 5 years (range 5 to 8.2). Patients were assessed clinically by the junior author (CW) and the results were standardised using the Hospital for Specialist Surgery (HSS) knee score. Standard radiographs were taken in AP and lateral planes to assess for loosening using the Knee Society roentgenographic system. Case notes were then examined for evidence of complications in the peri and postoperative complications. Sixty-five patients (71 knees) were reviewed. There was an excellent clinical outcome with HSS scores of 85 in 97.1% of patients. Two knees (2.9%) were revised, one for meniscal fracture and one for meniscal dislocation. Both these patients also attended for review and were making good progress. Both of these failures occurred early in our series and in a total of 312 knees to date there have been no other meniscal failures. No knees were revised for aseptic loosening and there have been no deep infections. We feel this prosthesis offers a safe and effective treatment for osteoarthritis with a good clinical outcome at 5 years with a low level of complications.
The Use of bone allograft in orthopaedic Surgery has been predicted to increase particularly in joint revision surgery. This has led to a potential problem with supply. Questionnaires were distributed to all 146 Consultant orthopaedic Surgeons working in Scotland in 2000. They were asked to indicate their current usage of bone and tissue allograft, any problems encountered with supply and if alternatives to allograft such as processed bone, might be used. The questions asked were very similar to those asked in a survey by the author (GG) in 1995 to enable comparisons to be made. 74% of all bone issued by the SNBTS in 2000 –2001 was used in revision hip arthroplasy. This compares with only 66% of bone issued in 1998–1999. Replies were received from 125 consultants (87%) of whom 93 reported using bone allograft. 41 consultants (46%) predicted an increase in their requirement for bone allograft, and 23 (26%) felt they could currently use more bone if this became available. Sixty percent of Surgeons would consider using processed bone as an alternative. In comparison with figures from a previous study in 1995, an increasing number of surgeons are prepared to use processed bone as an alternative to fresh frozen allograft. As the number of revision THR’ s continues to increase the amount of bone required is likely to continue to increase. The need to increase efficiency in harvest and supply of bone is therefore great. The use of more SNBTS nurses in selection of patients and collection of bone may increase efficiency. More surgeons may have to use processed bone, which would allow more bone to be released. Also processing may help reduce transmission of infective particles such as HIV and new variant CJD. With rising public and medical concerns over these issues this seems most desirable.
